All In Biotech

Drug Trial Radar · NCT03733444

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis

Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 781 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

781

Actual

Start

Nov 5, 2018

Primary completion

Mar 30, 2021

Study completion Mar 30, 2021

Sponsor

Lead sponsor
Lakefront Biotherapeutics NVIndustry
Sponsor type
Industry
First posted
Nov 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study was to see how GLPG1690 works together with the current standard treatment on your lung function and IPF disease in general. The study also investigated how well GLPG1690 is tolerated (for example if you get any side effects while on study drug).

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • GLPG1690Drug

    GLPG1690, film-coated tablets for oral use.

  • PlaceboDrug

    Matching placebo, film-coated tablets for oral use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annual Rate of Decline in Forced Vital Capacity (FVC) up to Week 52Time frame: Baseline up to week 52

Locations

132 sites in 15 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Arizona Pulmonary Specialists

    Phoenix, Arizona

  • University of Arizona College of Medicine

    Tucson, Arizona

  • Keck School of Medicine of USC

    Los Angeles, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • UC Davis Medical Center

    Sacramento, California

  • University of California, San Francisco Medical Center

    San Francisco, California

  • St. Francis Medical Institute

    Clearwater, Florida

  • University of Miami

    Miami, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Central Florida Pulmonary Group PA

    Orlando, Florida

  • Piedmont Healthcare

    Atlanta, Georgia

  • Emory University

    Atlanta, Georgia

  • University of Chicago Medical Center

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Brigham and Womens Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • University of Michigan Health System (UMHS)

    Ann Arbor, Michigan

  • Spectrum Health Medical Group

    Grand Rapids, Michigan

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • Cardio Pulmonary Associates

    Chesterfield, Missouri

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire

  • Atlantic Respiratory Institute

    Summit, New Jersey

  • Lovelace Scientific Resources Inc

    Albuquerque, New Mexico

  • Albany Medical Center

    Albany, New York

  • Columbia University Medical Center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Ohio State University

    Columbus, Ohio

  • Mercy Health - St. Vincent Medical Center

    Toledo, Ohio

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Temple Lung Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Medical University of South Carolina - PPDS

    Charleston, South Carolina

  • University of Vermont

    Burlington, Vermont

  • Inova Fairfax Hospital

    Falls Church, Virginia

  • Centro Médico Dra de Salvo

    Buenos Aires, Argentina

  • Hospital Privado Centro Médico de Córdoba

    Córdoba, Argentina

  • CEMER Centro Médico de Enfermedades Respiratorias

    Florida, Argentina

  • Hospital Zonal Especializado de Agudos y Crónicos Dr. Antonio A. Cetrangolo

    Luján, Argentina

Showing 40 of 132 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.